[go: up one dir, main page]

NO890174L - Rekombinante interleukin-1alfa-polypeptider. - Google Patents

Rekombinante interleukin-1alfa-polypeptider.

Info

Publication number
NO890174L
NO890174L NO89890174A NO890174A NO890174L NO 890174 L NO890174 L NO 890174L NO 89890174 A NO89890174 A NO 89890174A NO 890174 A NO890174 A NO 890174A NO 890174 L NO890174 L NO 890174L
Authority
NO
Norway
Prior art keywords
polypeptides
1alfa
dna sequences
recombinant interleukin
recombinant vectors
Prior art date
Application number
NO89890174A
Other languages
English (en)
Norwegian (no)
Other versions
NO890174D0 (no
Inventor
Peter T Lomedico
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO890174D0 publication Critical patent/NO890174D0/no
Publication of NO890174L publication Critical patent/NO890174L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO89890174A 1988-01-15 1989-01-13 Rekombinante interleukin-1alfa-polypeptider. NO890174L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14445788A 1988-01-15 1988-01-15

Publications (2)

Publication Number Publication Date
NO890174D0 NO890174D0 (no) 1989-01-13
NO890174L true NO890174L (no) 1989-07-17

Family

ID=22508674

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89890174A NO890174L (no) 1988-01-15 1989-01-13 Rekombinante interleukin-1alfa-polypeptider.

Country Status (19)

Country Link
EP (1) EP0324447B1 (da)
JP (1) JP2567079B2 (da)
AR (1) AR245958A1 (da)
AT (1) ATE142696T1 (da)
AU (1) AU616461B2 (da)
DE (1) DE58909723D1 (da)
DK (1) DK16489A (da)
ES (1) ES2091752T3 (da)
FI (1) FI890175A7 (da)
GR (1) GR3021887T3 (da)
HU (1) HU208996B (da)
IE (1) IE890087L (da)
IL (1) IL88934A (da)
MC (1) MC2002A1 (da)
NO (1) NO890174L (da)
NZ (1) NZ227594A (da)
PT (1) PT89438B (da)
YU (1) YU6889A (da)
ZA (1) ZA89202B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188920B1 (en) * 1984-12-25 1993-09-29 Dainippon Pharmaceutical Co., Ltd. Interleukin 1 and its derivative
DE3818660A1 (de) * 1987-06-05 1988-12-15 Colgate Palmolive Co Freifliessendes, pulvriges geschirrwaschmittel und verfahren zur herstellung desselben
EP0352816A3 (en) * 1988-07-29 1991-03-20 Otsuka Pharmaceutical Co., Ltd. Il-1alpha derivates and medicament for treating thrombocytopenia
US7176179B1 (en) 1997-05-30 2007-02-13 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US6191269B1 (en) * 1997-05-30 2001-02-20 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US20030154504A1 (en) 1998-06-24 2003-08-14 Farese Robert V. Methods and compositions for modulating carbohydrate metabolism
DE10252634A1 (de) * 2002-11-11 2004-05-27 Umwelttechnik Georg Fritzmeier Gmbh & Co. Reinigungsmittel und Verfahren zu seiner Herstellung
JP5661777B2 (ja) * 2009-09-29 2015-01-28 ユナイテッド・テクノロジーズ・ユーティー・アクチェンゲゼルシャフト 組換え型ヒトインターロイキン−１を含む口腔ケア組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188920B1 (en) * 1984-12-25 1993-09-29 Dainippon Pharmaceutical Co., Ltd. Interleukin 1 and its derivative
EP0200986B2 (en) * 1985-04-25 1998-03-11 F. Hoffmann-La Roche Ag Recombinant human interleukin-1
DE3515217A1 (de) * 1985-04-26 1986-10-30 Siemens AG, 1000 Berlin und 8000 München Vorrichtung zur messung schwacher magnetfelder
US5017692A (en) * 1986-09-04 1991-05-21 Schering Corporation Truncated human interleukin-a alpha

Also Published As

Publication number Publication date
IE890087L (en) 1989-07-15
AU2850989A (en) 1989-07-20
EP0324447B1 (de) 1996-09-11
DK16489D0 (da) 1989-01-13
FI890175L (fi) 1989-07-16
JPH025892A (ja) 1990-01-10
AU616461B2 (en) 1991-10-31
HU208996B (en) 1994-09-28
GR3021887T3 (en) 1997-03-31
EP0324447A2 (de) 1989-07-19
ZA89202B (en) 1989-09-27
JP2567079B2 (ja) 1996-12-25
ES2091752T3 (es) 1996-11-16
ATE142696T1 (de) 1996-09-15
EP0324447A3 (de) 1990-01-31
IL88934A (en) 1994-05-30
DK16489A (da) 1989-07-16
DE58909723D1 (de) 1996-10-17
YU6889A (en) 1990-08-31
FI890175A0 (fi) 1989-01-13
HUT50505A (en) 1990-02-28
PT89438A (pt) 1990-02-08
NZ227594A (en) 1991-09-25
FI890175A7 (fi) 1989-07-16
PT89438B (pt) 1993-09-30
AR245958A1 (es) 1994-03-30
IL88934A0 (en) 1989-08-15
NO890174D0 (no) 1989-01-13
MC2002A1 (fr) 1990-01-26

Similar Documents

Publication Publication Date Title
NZ223506A (en) Tissue factor protein, dna encoding it, vectors, host cells, production of the protein and pharmaceutical compositions
ATE205254T1 (de) Transformierender wachstumsfaktor alpha h1
ZA91134B (en) New proteins produced by human lymphocytes,dna sequence encoding these proteins and their pharmaceutical and biological uses
IL99401A0 (en) Nucleotide sequence coding for an outer membrane protein and use of said protein in vaccine preparations
ZA943464B (en) Vascular endothelial growth factor 2
ATE255128T1 (de) Peptid-immitierende substanzen in der krebstherapie
DE68929551D1 (de) Menschliche DNase
NO177678C (no) Fremgangsmåte for fremstilling av et terapeutisk aktivt, rekombinant protein som har ASP-aktivitet, ekspresjonssystem samt DNA som koder for nevnte protein
AU1026692A (en) Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
ATE267258T1 (de) Impfstoffe für das respiratorische-synzytial- virus mit nuklein säuren
ES8306324A1 (es) "proceso para la produccion microbiana de interferon fibroblasto humano".
NZ271756A (en) Human macrophage inflammatory proteins and coding sequences, their production and use
RU95106651A (ru) Аналоги дзе-тур динорфина и способ лечения толерантных состояний у пациента
AU1724795A (en) Human tissue inhibitor of metalloproteinase-4
NO873699D0 (no) Polypeptid som er egnet til dempning, behandling og diagnosering av autoimmune lidelser saasom leddbetennelser.
PT84089A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
NO890174L (no) Rekombinante interleukin-1alfa-polypeptider.
FI896261A7 (fi) Menetelmä proteiinin tai polypeptidin valmistamiseksi, polypeptidiä ko odaava DNA-sekvenssi, DNA-sekvenssin sisältämä mikro-organismi sekä po lypeptidi ja sen käyttö farmaseuttisena valmisteena
DK288789A (da) Peptider og syreadditionssalte deraf, deres fremstilling og anvendelse
ZA904565B (en) Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
LV11803A (lv) Nesplaisinga gp350/220 varianti
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
SG128403A1 (en) Tnf-receptors, tnf binding proteins and dnas coding for them
FR2636953A1 (fr) Nouveaux polypeptides produits par des lymphocytes humains, genes codant pour ces polypeptides et applications pharmaceutiques et biologiques
DK575287D0 (da) Anvendelse af vaevsfaktorprotein og antagonister herfor til fremstilling af laegemidler til behandling af bloedningsforstyrrelser samt farmaceutiske praeparater indeholdende disse